Auto-generated event page

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial

FDA has placed partial clinical hold on LINNET study of lorigerlimab in gynecologic cancer FDA has placed partial clinical hold on LINNET study of lorigerlimab in gynecologic ca...

Score 41 low confidence 1 source posts Updated Feb 23, 2026, 11:20 PM UTC

Track This Event Open Event in App More Signal Pages

Cluster sources

Newest source rows first.

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial

GlobeNewswire Public Companies • Feb 23, 2026, 11:14 PM UTC

Entity focus

Direct link to post

https://pushme.site/signals/123028-macrogenics-announces-pausing-of-enrollment-of-new-study-participants-in?utm_source=signal-123028&utm_medium=social&utm_campaign=signal-pages&utm_content=hero

Quick distribution loop

Step 1

Post this live link in threads where users ask how to monitor this event.

Step 2

Point readers to "Track This Event" for immediate conversion into an alert.

Step 3

Reuse entity keywords from this page for targeted follow-up replies.

Back to signal pages Open query hub